The emerging role of caspase inhibitors in gastrointestinal cancers

Journal of Gastroenterology

Volumn 37, Issue 5, 2002, Pages 323-331

  Shiraki, Katsuya ^a   Takase, Kaujiro ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Caspase; Caspase inhibitors; Gastrointestinal cancer; Inhibitor of apoptosis family

Indexed keywords

CASPASE 8; CASPASE INHIBITOR; FLICE INHIBITORY PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SURVIVIN; BIRC5 PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE; CFLAR PROTEIN, HUMAN; DIABLO PROTEIN, HUMAN; ENZYME INHIBITOR; HSXIAPAF1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE; TUMOR PROTEIN;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION; X CHROMOSOME LINKAGE; DRUG ANTAGONISM; GASTROINTESTINAL TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY;

APOPTOSIS; CARRIER PROTEINS; CASPASES; ENZYME INHIBITORS; GASTROINTESTINAL NEOPLASMS; HUMAN; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; NF-KAPPA B; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;

EID: 0035991208     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200045     Document Type: Review

References (113)

1. An evolutionary perspective on apoptosis
2. Apoptosis in the pathogenesis and treatment of disease
3. Apoptosis by death factor
4. Apoptosis in the liver and its role in hepatocarcinogenesis
5. Dysregulation of apoptosis in hepatocellular carcinoma
6. Resistance to Fas-mediated apoptosis in human hepatoma cells
7. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines
8. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
9. Caspases: The executioners of apoptosis
10. Caspases: Enemies within
11. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β converting enzyme
12. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1-β-converting enzyme
13. Immunohistochemical analysis of in vivo patterns of expression of CPP32(caspase-3), a cell death protease
14. Apoptosis signaling by death receptors
15. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
16. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
17. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
18. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
19. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
20. Caspase inhibitors
21. Transcriptional repression of the human p53 gene by hepatitis B viral X protein
22. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
23. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis
24. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1
25. Activation of p53 tumor suppressor by hepatitis C virus core protein
26. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation
27. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer
28. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion?
29. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma
30. Inhibition of death receptor signals by cellular FLIP
31. The Bcl-2 protein family: Arbiters of cell survival
32. Escaping cell death: Survival proteins in cancer
33. IAP family proteins-suppressors of apoptosis
34. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
35. Expression of functional CD40 in human hepatocellular carcinoma
36. Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via akt activation and Fas-death-inducing signaling complex suppression
37. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors
38. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors
39. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
40. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
41. A human IAP-family gene, Apollon, expressed in human brain cancer cells
42. Livin, a novel inhibitor-of-apoptosis (IAP) family member
43. X-linked IAP is a direct inhibitor of cell-death proteases
44. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
45. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control
46. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
47. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement
48. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
49. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
50. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors
51. Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma
52. Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer
53. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis
54. Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy
55. Survivin as a radioresistance factor in pancreatic cancer
56. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment
57. Survivin promotes cell proliferation in human hepatocellular carcinoma
58. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
59. Survivin initiates procaspase3/p21 complex as a result of interaction with cdk4 to resist Fas-mediated cell death
60. INKa4 and cdk2/cyclin E complex activation
61. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
62. Expression of the inhibitor of apoptosis, survivin, in liver regeneration
63. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
64. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
65. Cancer gene therapy using a survivin mutant adenovirus
66. Inhibition of melanoma tumor growth in vivo by survivin targeting
67. Control of apoptosis and mitotic spindle checkpoint by survivin
68. Survivin' cell-separation anxiety
69. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma
70. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias
71. Identification of XIAP as a principal inhibitor of caspase 3 overexpressed in human hepatocellular carcinomas
72. Resistance to Fas-mediated apoptosis: Activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP
73. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection
74. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: Role of La autoantigen in XIAP translation
75. XIAP: Apoptotic brake and promising therapeutic target
76. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
77. Inhibitor of apoptosis-protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis
78. NF-κB/Rel/IκB: Implications in gastro-intestinal diseases
79. NF-kappaB signals induce the expression of c-FLIP
80. The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of cIAP1 and 2
81. Cytochrome c: Can't live with it-can't live without it
82. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
83. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
84. Structural basis of IAP recognition by Smac/DIABLO
85. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
86. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway
87. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
88. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
89. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery
90. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcriptional factor
91. Regulation of cell death protease caspase-9 by phosphorylation
92. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells
93. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)
94. The opposing roles of the Akt and c-myc signaling pathways in survival from CD95-mediated apoptosis
95. Molecular cloning and expression of human hepatocyte growth factor
96. Hepatocyte growth factor for liver disease
97. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers
98. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model
99. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway
100. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinoma via Ras-mediated pathway
101. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway
102. Apoptosis by death factor
103. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95)
104. The receptor for the cytotoxic ligand TRAIL
105. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
106. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
107. Casper is a FADD- and caspase-related inducer of apoptosis
108. Expression and function of FLIP (FLICE/caspase 8-inhibitory protein) in human hepatocellular carcinoma cells
109. Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway
110. The role of c-FLIP in modulation of CD95-induced apoptosis
111. p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
112. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
113. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)